期刊文献+

非糖尿病维持性血液透析患者髓过氧化物酶与颈动脉硬化的相关性 被引量:1

Correlation of Myeloperoxidase and Carotid Atherosclerosis in Non-diabetic Patients with Maintenance Hemodialysis
下载PDF
导出
摘要 目的探讨非糖尿病维持性血液透析患者髓过氧化物酶与颈动脉硬化相关指标的关系。方法酶联免疫吸附法测定非糖尿病维持性血液透析患者同一次透析前后血浆髓过氧化物酶和血清弹性蛋白酶水平变化,同时B超测定两侧颈总动脉内膜中膜厚度、斑块数量及面积,并对各项指标做相关性分析。结果血液透析后血浆髓过氧化物酶水平明显高于血液透析前(P<0.01),血清弹性蛋白酶水平透析前后无明显变化。年龄、血液透析前髓过氧化物酶水平与颈总动脉内膜中膜厚度明显正相关(P<0.01),血液透析后髓过氧化物酶水平与血液透析前后弹性蛋白酶水平无相关,与各项颈动脉硬化指标也无相关。结论年龄及血液透析前髓过氧化物酶水平与动脉硬化有关,而特定血液透析条件时血液透析后血浆髓过氧化物酶水平的升高与中性粒细胞脱颗粒及动脉硬化程度无关,可能是肝素诱发的动脉壁髓过氧化物酶释放,这种释放对维持性血液透析患者动脉硬化的意义有待进一步研究。 Aim To study possible clinical relationships of myeloperoxidase(MPO) and carotid atherosclerosis in non-diabetic patients with maintenance hemodialysis(MHD).Methods Levels of plasma MPO and serum elastase(ELT) of non-diabetic patients with MHD were determined by ELISA.Carotid intima-media thickness(IMT),quantity and area of carotid plaque were measured by B-mode ultrasonography.Results There was no significant difference of serum ELT before and after hemodialysis(HD).Plasma MPO was significantly higher after HD than before HD(P0.01).There was positive correlation between age,MPO level before HD and carotid IMT(P0.01).There was no correlation between the levels of plasma MPO after HD and serum ELT or carotid IMT.Conclusions MPO level before HD contributed to carotid atherosclerosis in patients on MHD.In contrast,there was no relation between higher MPO level after HD and carotid atherosclerosis.This finding suggests that increased plasma MPO levels after HD do not reflect increased activation/degranulation of leukocytes and supports the view that the increase in circulating MPO reflects the heparin-induced release from the atherosclerotic vascular wall.
出处 《中国动脉硬化杂志》 CAS CSCD 北大核心 2011年第11期919-922,共4页 Chinese Journal of Arteriosclerosis
基金 山东省自然科学基金(y2007c114)
关键词 维持性血液透析 髓过氧化物酶 颈动脉粥样硬化 Maintenance Hemodialysis Myeloperoxidase Carotid atherosclerosis
  • 相关文献

参考文献12

  • 1Honda H, Ueda M, Kojima S, et al. Assessment of my- eloperoxidase and oxidative cd-antitrypsin in patients on hemodialysis[J]. Clin J Am Soc Nephrol, 2009, 4 (1) : 142-151.
  • 2Rudolph V, Rudolph TK, Schopfer FJ, et al. Bivalirudin decreases NO bioavailability by vascular immobilization of myeloperoxidase[ J]. J Pharmacol Exp Ther, 2008, 327 (2) : 324-331.
  • 3A1-Hweish A, Sultan SS, Mogazi K, et al.Plasma my- eloperoxidase, NT-proBNP, and troponin-I in patients on CAPD compared with those on regular hemodialysis [ J ]. Hemodial Int, 2010, 14 (3) : 308-315. ~.
  • 4Nicholls S J, Hazen SL. Myeloperoxidase and cardiovascu- lar disease[ J]. Arterioscler Thromb Vasc Biol, 2005, 25 (6): 1 102-111.
  • 5Borawski J, Naumnik B, Rydzewska-Roso~owska A, et al. Myeloperoxidase as a marker of hemodialysis biocompati- bility and oxidative stress: the underestimated modifying effects of heparin [ J ]. Am J Kidney Dis, 2006, 47 ( 1 ) : 37-41.
  • 6Sela S, Shurtz-Swirski R, Cohen-Mazor M, et al. Primed peripheral polymorphonuclear leukocyte: a culprit underly- ing chronic low-grade inflammation and systemic oxidative stress in chronic kidney disease [ J ], J Am Soc Nephrol, 2005, 16:2 431-438.
  • 7Scheffer PG, van der Zwan LP, Schindhelm RK, et al. Myeloperoxidase concentrations in EDTA-plasma of healthy subjects are discordant with concentrations in heparin-plas- ma and serum[J]. Clin Biochem, 2009, 42 (13-14) : 1 490-492.
  • 8Krieter DH, Morgenroth A, Barasinski A, et al. Effects of a polyelectrolyte additive on the selective dialysis mem- brane permeability for low-molecular-weight proteins [ J ]. Nephrol Dial Transplant, 2007, 22 (2) : 491-499.
  • 9Powell AK, Yates EA, Fernig DG, et al. Interactions of heparin/heparan sulfate with proteins: Appraisal of struc- tural factors and experimental approaches [ J ]. Glycobiolo- gy, 2004, 14: 17R-30R.
  • 10Liu J, Pedersen LC. Anticoagulant heparan sulfate : struc- tural specificity and biosynthesis [ J ]. Appl Microbiol Bio- technol, 2007, 74 (2) : 263-272.

同被引文献20

  • 1Buffon A, Biasucci LM, Liuzzo G, et al. Widespread coronary inflammation in unstable angina [Jl. N Engl J Med, 2002, 347 (1): 5-12.
  • 2Libby P, Theroux P. Pathophysiology of coro- nary artery disease [ J ]. Circulation, 2005, 111 (25): 3481 -3488.
  • 3Shao B, Pennathur S, Heinecke JW. My- eloperoxidase targets apolipoprotein A -I, the major high density lipoprotein protein, for site -specific oxidation in human atheroselerotie lesions [ J ]. J Biol Chem, 2012, 287 (9): 6375 -6386.
  • 4Cook NL, Viola HM, Sharov VS, et al. My- eloperoxidase- derived oxidants inhibit sareo/ endoplasmie retieulum Ca2 + - ATPase activity and perturb Ca2 + homeostasis in human coro- nary artery endothelial cells [ J ]. Free Radie BiolMed, 2012, 52 (5): 951-961.
  • 5Chen LQ, Rohatgi A, Ayers CR, et al. Race - specific associations of myeloperoxi- dase with atheroselerosis in a population - based sample: the Dallas Heart Study [ Jl. Atheroselerosis, 2011, 219 ( 2 ) : 833 - 838.
  • 6Chen L, Ling YS, Lin CH, et al. Combined use of heparin and anisodamine reduces the risk of early thrombosis in native arteriovenous fistu- la [J]. Vascular, 2013. [Epub ahead of print ].
  • 7Powell AK, Yates EA, Fernig DG, et al. Interactions of heparin/heparan sulfate withproteins: appraisal of structural factors and experimental approaches [ J ]. Glycobiology, 2004, 14 (4): 17R-30R.
  • 8Zheng L, Nukuna B, Brennan ML, et al. Apollpoprotein A - I is a selective target for myeloperoxidase - catalyzed oxidation and functional impairment in subjects with cardio- vascular disease [ J]. J Clin Invest, 2004, 114 (4): 529-541.
  • 9Bergt C, Pennathur S, Fu X, et al. The myeloperoxidase product hypochlorous acid oxidizes HDL in the human artery wall and impairs ABCA1 - dependent cholesterol transport [ J ]. Proc Natl Acad Sci USA, 2004, 101 (35): 13032-13037.
  • 10Podrez EA, Febbraio M, Sheibani N, et al. Macrophage scavenger receptor CD36 is the major receptor for LDL modified by monocyte -generated reactive nitrogen species [ J ]. J Clin Invest, 2000, 105 (8): 1095 - 1108.

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部